-+ 0.00%
-+ 0.00%
-+ 0.00%

Kala Bio Q3 EPS $(1.07) Beats $(1.45) Estimate

Benzinga·11/19/2025 15:16:54
Listen to the news
Kala Bio (NASDAQ:KALA) reported quarterly losses of $(1.07) per share which beat the analyst consensus estimate of $(1.45) by 25.95 percent. This is a 44.56 percent increase over losses of $(1.93) per share from the same period last year.